Fenglong Xie

6.0k total citations
140 papers, 4.3k citations indexed

About

Fenglong Xie is a scholar working on Rheumatology, Epidemiology and Hematology. According to data from OpenAlex, Fenglong Xie has authored 140 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Rheumatology, 39 papers in Epidemiology and 27 papers in Hematology. Recurrent topics in Fenglong Xie's work include Rheumatoid Arthritis Research and Therapies (56 papers), Systemic Lupus Erythematosus Research (27 papers) and Autoimmune and Inflammatory Disorders Research (26 papers). Fenglong Xie is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (56 papers), Systemic Lupus Erythematosus Research (27 papers) and Autoimmune and Inflammatory Disorders Research (26 papers). Fenglong Xie collaborates with scholars based in United States, Germany and Canada. Fenglong Xie's co-authors include Jeffrey R. Curtis, Lang Chen, Huifeng Yun, Kevin Winthrop, Kenneth G. Saag, Elizabeth Delzell, James D. Lewis, Timothy Beukelman, John W. Baddley and Sasha Bernatsky and has published in prestigious journals such as JAMA, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Fenglong Xie

129 papers receiving 4.2k citations

Peers

Countries citing papers authored by Fenglong Xie

Since Specialization

Citations

This map shows the geographic impact of Fenglong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglong Xie more than expected).

Fields of papers citing papers by Fenglong Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglong Xie. The network helps show where Fenglong Xie may publish in the future.

Co-authorship network of co-authors of Fenglong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglong Xie. A scholar is included among the top collaborators of Fenglong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglong Xie. Fenglong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Methanol-driven co-metabolic enhancement of benzotriazole and 5-chlorobenzotriazole degradation by Chlorella pyrenoidosa: Mechanisms, transformation pathways, and metabolic insights 2025 ·Journal of Hazardous Materials ·Jie Ma, Qian Xiong, (unknown), Hengyu Wu, Fenglong Xie, Yanfen Chen, Qinglin Tang, Yuqin Zou, Xinyan Huang, You‐Sheng Liu, Guang‐Guo Ying	0
2	Survival in Immune Checkpoint Inhibitor–Treated Patients With Rheumatoid Arthritis and Non–Small Cell Lung Cancer: An Observational Cohort Study 2025 ·Arthritis Care & Research ·Deanna Jannat‐Khah, Fenglong Xie, Ashish Saxena, Jeffrey R. Curtis, Anne R. Bass	0
3	A metabolic enzyme-photosynthetic machinery involved in the co-metabolism of enrofloxacin and ciprofloxacin by Chlorella pyrenoidosa 2025 ·Journal of Hazardous Materials ·Hengyu Wu, Qian Xiong, (unknown), Yichun Wang, Haigang Chen, Fenglong Xie, Jie Ma, Qinglin Tang, Yanfen Chen, (unknown), (unknown), You‐Sheng Liu, Guang‐Guo Ying	1
4	Are Glucocorticoids Associated With Worse Survival Among Patients With Rheumatoid Arthritis and Lung Cancer Treated With Immune Checkpoint Inhibitors? 2025 ·Arthritis & Rheumatology ·Deanna Jannat‐Khah, Jeffrey R. Curtis, Fenglong Xie, Ashish Saxena, Anne R. Bass	0
5	Buprenorphine Dispensation After X-Waiver Elimination by Clinician Specialty 2025 ·American Journal of Preventive Medicine ·Elizabeth M. Stone, Fenglong Xie, Jennifer Miles, Hillary Samples, Mark Olfson, Stephen Crystal	0
6	The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical Outcomes 2025 ·Arthritis & Rheumatology ·(unknown), (unknown), (unknown), (unknown), Fenglong Xie, Jingyi Zhang, Grace C. Wright, Jeffrey R. Curtis, Gail S. Kerr	0
7	Where We Live Matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United States 2025 ·Arthritis & Rheumatology ·(unknown), (unknown), (unknown), (unknown), Fenglong Xie, Jingyi Zhang, Grace C. Wright, Jeffrey R. Curtis, Gail S. Kerr	0
8	Wearable activity tracker study exploring rheumatoid arthritis patients’ disease activity using patient-reported outcome measures, clinical measures, and biometric sensor data (the wear study) 2024 ·Contemporary Clinical Trials Communications ·(unknown), Jeffrey R. Curtis, Patrick Zueger, Fenglong Xie, David Curtis, Kelly Gavigan, (unknown), Shilpa Venkatachalam, (unknown), W. Benjamin Nowell	2
9	Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United States 2024 ·Arthritis & Rheumatology ·Melissa L. Mannion, Fenglong Xie, John FitzGerald, (unknown), Amy S. Mudano, Yujie Su, Kenneth G. Saag, Jeffrey R. Curtis	2
10	Real‐World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory Therapy 2024 ·Arthritis Care & Research ·(unknown), Amy S. Mudano, Fenglong Xie, Jingyi Zhang, Ted R. Mikuls, Ken Saag, Huifeng Yun, Brian LaMoreaux, Megan Francis‐Sedlak, Jeffrey R. Curtis	2
11	POS1460-HPR PREVALENCE AND MANAGEMENT OF PATIENTS WITH COMORBIDITIES AND FRAILTY IN NEW ONSET POLYMYALGIA RHEUMATICA 2024 ·Annals of the Rheumatic Diseases ·Sebastian E. Sattui, Frank Buttgereit, (unknown), (unknown), Stefano Fiore, Luiz H. Araujo, Timothy Beukelman, Fenglong Xie, J. Randall Curtis	1
12	Research on load prediction of carrier-based aircraft landing test based on measured data 2024 ·Journal of Physics Conference Series ·Fenglong Xie, Wei Xu	1
13	Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation 2024 ·Arthritis Research & Therapy ·(unknown), Amy S. Mudano, Fenglong Xie, Jingyi Zhang, Ted R. Mikuls, Brian LaMoreaux, Lissa Padnick‐Silver, Jeffrey R. Curtis	0
14	The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare 2023 ·Bone ·Ye Liu, Tarun Arora, Jingyi Zhang, (unknown), Fenglong Xie, Jeffrey R. Curtis	1
15	Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study 2023 ·JMIR Human Factors ·W. Benjamin Nowell, Jeffrey R. Curtis, (unknown), Fenglong Xie, (unknown), David Curtis, Kelly Gavigan, (unknown), (unknown), Ilya Lipkovich, Shilpa Venkatachalam, Amy O. Calvin, (unknown)	5
16	Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry 2022 ·ACR Open Rheumatology ·Melissa L. Mannion, Fenglong Xie, Timothy Beukelman, (unknown)	3
17	The Economic Benefit of Remission for Patients with Rheumatoid Arthritis 2022 ·Rheumatology and Therapy ·Jeffrey R. Curtis, Kathleen M. Fox, Fenglong Xie, Yujie Su, David H. Collier, (unknown), (unknown)	9
18	Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry 2020 ·The Journal of Rheumatology ·Melissa L. Mannion, Fenglong Xie, Daniel B. Horton, Sarah Ringold, C. Correll, Anne Dennos, Timothy Beukelman	14
19	Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease 2018 ·The American Journal of Gastroenterology ·James D. Lewis, Frank I. Scott, Colleen Brensinger, Jason Roy, Mark T. Osterman, Ronac Mamtani, Meenakshi Bewtra, Lang Chen, Huifeng Yun, Fenglong Xie, Jeffrey R. Curtis	109
20	Human FasL Gene Is a Target of β-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions 2011 ·PLoS ONE ·Jianming Wu, Maureen Richards, Jinhai Huang, Lena Al‐Harthi, Xiulong Xu, Rui Lin, Fenglong Xie, Andrew Gibson, Jeffrey C. Edberg, Robert P. Kimberly	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact